Company Profile
Updated: 30-NOV-09Boehringer Ingelheim France S.A.S.
International Private company
14 rue Jean Antoine de Baif, Paris, F-75644 Cedex 13, France
()33 01 44 34 65 65, 33 01 44 34 65 00 fax, http://www.boehringer-ingelheim.fr
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Holding company with interests in the manufacture of pharmaceuticals specialising in prescription medicines, consumer health care, animal health and pharma chemicals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018.
Biotech Week; 12/30/2009; 941 words; ...Resources, one of the world's leading research and advisory...in the United States, France, Germany, Italy, Spain...anticoagulants, most notably Boehringer Ingelheim's Pradaxa and Bayer/Johnson & Johnson's Xarelto, will drive significant...
Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and forecast.
M2 Presswire; 12/22/2009; 913 words; ...Italy, Spain, Germany, France, and Japan. - Pipeline...Inhibitors, glutathione S-transferase binders...AG, Sanofi-aventis, Boehringer Ingelheim GmbH, and Abraxis BioScience...partnerships. - What's the next big thing in the...
United States : Reportlinker Adds The Future of Contract Manufacturing - Market Forecasts To 2015 and Geographical Trends.
TendersInfo; 12/17/2009; 800 words; ...house analysis by GBI Research's team of industry experts. The scope...world - the US, the UK, Germany, France, Italy, Spain, and Japan. Key...Biologics, Catalant, DSM, Sandoz and Boehringer Ingelheim. Key M&A activities, licensing...
Reportlinker Adds The Future of Contract Manufacturing - Market Forecasts To 2015 and Geographical Trends.
PR Newswire; 12/15/2009; 1793 words; ...analysis by GBI Research's team of industry experts...the UK, Germany, France, Italy, Spain, and...Catalant, DSM, Sandoz and Boehringer Ingelheim. - Key M&A activities...9.9 Cambrex 9.10 Boehringer Ingelheim 10 Strategic Consolidations...
Reportlinker Adds Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015.
PR Newswire; 12/15/2009; 2044 words; ...analysis specialist's new report, "Acute...analysis by GlobalData's team of industry experts...Spain, Germany, France, and Japan. - Pipeline...Myers Squibb and Boehringer Ingelheim are found to be the...partnerships. - What's the next big thing...
Recent News Articles
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning